CN Patent

CN106166295A — 一种治疗病毒性腹泻的干扰素口服制剂

Assigned to Hangzhou Xianweida Biotechnology Co ltd · Expires 2016-11-30 · 9y expired

What this patent protects

本发明提供了一种干扰素口服肠溶制剂，所述的肠溶制剂有空白层、干扰素含药层以及肠溶衣层组成，并且所述的口服肠溶制剂不含有蛋白酶抑制剂和/或吸收促进剂，本发明所述制剂配方简单，对病毒性腹泻具有很好的预防和治疗效果。

USPTO Abstract

本发明提供了一种干扰素口服肠溶制剂，所述的肠溶制剂有空白层、干扰素含药层以及肠溶衣层组成，并且所述的口服肠溶制剂不含有蛋白酶抑制剂和/或吸收促进剂，本发明所述制剂配方简单，对病毒性腹泻具有很好的预防和治疗效果。

Drugs covered by this patent

Patent Metadata

Patent number
CN106166295A
Jurisdiction
CN
Classification
—
Expires
2016-11-30
Drug substance claim
No
Drug product claim
No
Assignee
Hangzhou Xianweida Biotechnology Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.